A phase 1 study of Respiratory syncytial virus (RSV) vaccine (ITV-RSV-DG) in healthy adults
Latest Information Update: 21 Aug 2020
At a glance
- Drugs Respiratory syncytial virus vaccine-Intravacc (Primary)
- Indications Respiratory syncytial virus infections
- Focus Adverse reactions
- 21 Aug 2020 New trial record
- 17 Aug 2020 Results published an Intravacc media release.
- 17 Aug 2020 According to an Intravacc media release, the results from this study were published in the medical journal Vaccine.